Table 1 Radiolabelled ch806 serum stability at 37°C

From: Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR

Time (day)

0

4

7

111In-ch806 radio purity (%)

99.5

97.4

96.9

111In-ch806 IR (%)

69.5

63.7

66.7

125In-ch806 radio purity (%)

99.0

95.6

95.0

125In-ch806 IR (%)

68.1

62.2

63.2

Back to article page